Biomarker Discovery Accelerated - Limited time offers available

Biomarker discovery doesn’t have to be slow or uncertain.

From early-stage screening to translational research, scientists are under pressure to deliver faster, more reproducible results, without compromising data quality. Fragmented workflows, manual steps, and inconsistent assay performance can slow progress and introduce variability.
 
That’s why Abcam and Molecular Devices have partnered to simplify biomarker discovery. Our integrated solutions—combining validated ELISA and metabolism assay kits with automation-ready plate readers and analysis software—streamline every step of the workflow, from quantification to functional analysis.
 
Whether you're working in oncology, immunology, or cell and gene therapy, our tools are designed to deliver trusted results with unmatched sensitivity, speed, and reproducibility, so you can confidently move from discovery to decision.

 


Spotlight solutions

Smarter ELISAs for faster decisions

Abcam’s SimpleStep ELISA® and CatchPoint® ELISA kits are designed for speed, sensitivity, and reproducibility—without the complexity.

  • One-wash, 90-minute protocols,

  • Colorimetric or fluorescent readouts with extended dynamic range,

  • Validated in biological samples and calibrated to WHO/NIBSC standards when available,

  • Available in 96- and 384-well formats for high-throughput labs.

Whether you're quantifying cytokines, growth factors, or metabolic markers, our ELISA kits deliver publication-ready data with minimal hands-on time.

Discover SimpleStep ELISA® kits, CatchPoint® SimpleStep ELISA® kits, and Metabolism assay kits. 

Learn more

elisa-simplestep-protocol-graphic

Optimized for SpectraMax® i3x microplate readers with SoftMax® Pro analysis

Molecular Devices’ SpectraMax® iSeries readers and SoftMax® Pro software are engineered to deliver high-throughput, high-confidence biomarker quantification—whether you're running ELISAs, metabolism assays, or Western blots.
 
  • Over 20,000 peer-reviewed publications using SpectraMax readers,
  • Detect as low as 50 pg/mL of dsDNA or sub-picogram protein levels with TRF, 

  • Read 6–384-well plates with up to 6 wavelengths per read,
  • Reduce validation time from 6 months to 3 days with SoftMax® Pro GxP,
  • Trusted by the top 50 global pharma companies,
  • GxP-ready: FDA 21 CFR Part 11 and EudraLex Annex 11 compliance, audit trails, electronic signatures.
Whether you need absorbance, fluorescence, luminescence, or more, the SpectraMax microplate readers offer modular flexibility and automation compatibility to scale with your lab.
 

Learn more


Application highlights

Non-destructive biomarker quantification in organoids

Organoids are powerfulApplication Note - High-Throughput hALT Assay for 3D Liver Microtissues—but precious. That’s why researchers are turning to non-destructive assays like the Abcam ALT ELISA kit, paired with the SpectraMax® ABS Plus reader.

This high-throughput solution enables single-wash quantification of liver biomarkers—ideal for toxicity and viability studies in 3D models.

Learn more

Western blot detection—without the darkroom

Traditional blotting ishttps://www.moleculardevices.com/en/assets/app-note/br/detection-and-quantitation-of-protein-with-scanlater-western-blot-detection slow and manual. The ScanLater™ Western Blot System transforms your SpectraMax® i3x or Paradigm reader into a blot imager—no film, no chemiluminescence.

With TRF-based detection and SoftMax® Pro, you get sub-picogram sensitivity and stable signals—ideal for multiplexed protein quantification.

Learn more

Multiplex-ready tools for cancer biomarker discovery

Cancer is complex, Abcam-eBook-CancerBiomarkersand so are its markers. That’s why researchers rely on Abcam antibody panels and ELISA kits to detect key biomarkers like PD-L1, HER2, and ctDNA.

These tools support early detection, treatment monitoring, and multi-omics workflows across oncology research.

Learn more


Customer Stories

Dr. Janine Erler at the university of Copenhagen

A breakthrough in metastasis research

The Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen is using the SpectraMax® Paradigm reader and ScanLater™ Western Blot Detection System to uncover how the tumor microenvironment drives cancer progression.

Learn how modular, multi-mode detection is helping them quantify protein expression in complex systems—and how it could help you too.

Learn more

A partnership that redefined antibody development

At the National Cancer Institute, Dr. Houssein Abdul Sater partnered with Abcam to develop a PD-L1 antibody panel that could detect subtle differences in immune checkpoint expression.


This collaboration helped accelerate biomarker discovery in tumor microenvironments—laying the groundwork for more precise immunotherapy research.

Learn more

Dr. Houssein Abdul Sater at National Cancer Institute

 

Let’s build your biomarker workflow

Tell us a bit about your research,  and we’ll help you design a workflow that fits your goals—from ELISA to automation.

 

Don't miss our offers:

Up to 20% on SpectraMax i3x Multi-Mode Microplate Reader AND

UP to 50% on Abcam SimpleStep ELISA or Metabolism Assay

*Terms and conditions apply, see details below. 

 

Speak to an expert

*Terms & Conditions:
Abcam:  For first-time customers buying any Assay Kit, get 50% off one assay from Abcam.  Full terms and conditions can be found here: Abcam Progress Happens Together.
Molecular Devices: Purchase order must reference promotion code 2025MDBIOPRO. The offer is to purchase the SpectraMax i3x Multi-Mode Microplate Reader for up to 20% off list price. Valid August 01, 2025 through May 29, 2026. The offer does not include shipping and handling, installation or training. The offer does not include any other options or accessories. This promotion cannot be combined with any other promotions or discounts. No substitutions or swap outs. The discount is not convertible to cash. Promotion is not valid for standing orders. All prices exclude delivery charges and local taxes, which are the responsibility of the customer. This offer is valid only to new customers in Europe when buying directly from Molecular Devices. Delivery terms are FCA (Free Carrier) and seller’s shipping facility (Incoterms 2010). Offer void where prohibited. All Molecular Devices products are for research use only. Other restrictions may apply. For our full standard terms and conditions of sale, please visit https://www.moleculardevices.com/terms-and-conditions.

 

MD-IMG-SpectraMax iD5e multi mode microplate reader_no background_400x200-2

SpectraMax® iD5e Multi-Mode Microplate Reader

Absorbance, fluorescence, and luminescence. In addition, the iD5e reader measures TRF and FP. Can be expanded to include TR-FRET, HTRF®, BRET, dual luciferase reporter assays with injectors, and western blot detection.

 

MD-IMG-M-Paradigm_no-background

SpectraMax Paradigm Multi-Mode Microplate Reader

Absorbance, fluorescence, fluorescence polarization, luminescence, and time-resolved fluorescence. Programmable liquid handling allows for automated biochemical and cell-based assays

MD-IMG-SpectraMax-ABS-microplate-reader_transparent-background_400x250px

SpectraMax® ABS Plus Microplate Reader

Fast and compact absorbance microplate readers provide the flexibility, sensitivity, and convenience for a wide range of assays such as ELISAs, microbial growth, and protein quantitation without the use of filters

Molecular Devices: A life science company

We journey alongside researchers, combining next-gen technology and deep expertise to spark bold breakthroughs that push research boundaries and transform lives worldwide.
citation
solutions_in_labs_worldwide
hardware software platforms

We're a trusted life sciences partner to researchers around the world

about-us-map